Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2150236 | 0.86 | THRB (0.52) | THRBLMNAL3MBTL1ALDH1A1 | |
| SCHEMBL21855415 | 0.86 | THRB (0.50) | THRBLMNAALDH1A1USP2CYP3A4 | |
| E968 SCHEMBL29094185 | 0.85 | THRB (0.65) | THRBLMNAL3MBTL1TDP1ALDH1A1 | |
| SCHEMBL3187648 | 0.82 | TDP1 (0.57) | THRBLMNAL3MBTL1TDP1ALDH1A1 | |
| SCHEMBL10559212 | 0.80 | USP2 (0.42) | THRBLMNAL3MBTL1USP2CYP3A4 | |
| SCHEMBL13496631 | 0.80 | THRB (0.50) | THRBLMNAALDH1A1 | |
| SCHEMBL8927312 | 0.80 | THRB (0.43) | THRBLMNAL3MBTL1TDP1ALDH1A1 | |
| SCHEMBL1703993 | 0.79 | LMNA (0.50) | THRBLMNAL3MBTL1TDP1ALDH1A1 | |
| SCHEMBL7147703 | 0.79 | LMNA (0.50) | THRBLMNAL3MBTL1TDP1ALDH1A1 | |
| SCHEMBL1703992 | 0.79 | LMNA (0.50) | THRBLMNAL3MBTL1TDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4504883-B1 | FABRIC TREATMENT COMPOSITIONS WITH ANTIOXIDANT MULTIMERS | PROCTER & GAMBLE (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-4504883-A1 | FABRIC TREATMENT COMPOSITIONS WITH ANTIOXIDANT MULTIMERS | The Procter & Gamble Company (US) | 2025-02-12 | — | — | EP | disclosed |
| EP-4463534-A1 | TREATMENT COMPOSITIONS WITH MODIFIED AMINO ACID MULTIMERS | The Procter & Gamble Company (US) | 2024-11-20 | — | — | EP | disclosed |
| US-20230323250-A1 | FABRIC TREATMENT COMPOSITIONS WITH ANTIOXIDANT MULTIMERS | THE PROCTER & GAMBLE COMPANY | 2023-10-12 | — | — | US | disclosed |
| WO-2023196452-A1 | FABRIC TREATMENT COMPOSITIONS WITH ANTIOXIDANT MULTIMERS | THE PROCTER & GAMBLE COMPANY (US) | 2023-10-12 | — | — | WO | disclosed |
| WO-2023137409-A1 | TREATMENT COMPOSITIONS WITH MODIFIED AMINO ACID MULTIMERS | THE PROCTER & GAMBLE COMPANY (US) | 2023-07-20 | — | — | WO | disclosed |
| US-20230220300-A1 | TREATMENT COMPOSITIONS WITH MODIFIED AMINO ACID MULTIMERS | THE PROCTER & GAMBLE COMPANY | 2023-07-13 | — | — | US | disclosed |
| JP-2006111554-A | COSMETIC AND METHOD FOR PRODUCING THE SAME | ODA TSUGIO | 2006-04-27 | — | — | JP | disclosed |
| US-5705184-A | YEAST EXTRACTS AND GLUCAN FOR SKIN DISORDERS | BIOPOLYMER ENGINEERING, INC. DBA BIOTHERA | 1998-01-06 | — | — | US | disclosed |
| US-5702719-A | GRINDING YEAST EXTRACT | BIOTHERA HOLDING CORP./BIOTHERA, INC. FORMERLY KNOWN AS BIOPOLYMER ENGINEERING, INC. | 1997-12-30 | — | — | US | disclosed |
| US-5576015-A | Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses | BIOPOLYMER ENGINEERING, INC. DBA BIOTHERA | 1996-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230220300-A1 | TREATMENT COMPOSITIONS WITH MODIFIED AMINO ACID MULTIMERS | BCAT2, MTR, ASNS | THRB 4774/4885LMNA 793/4885L3MBTL1 4218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.